Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13552273 | 0.86 | MAPT (0.56) | MAPTHPGDMEN1KMT2ANPSR1 | |
| SCHEMBL11636094 | 0.84 | KMT2A (0.46) | MAPTMEN1KMT2ALMNA | |
| SCHEMBL77732 | 0.82 | MEN1 (0.63) | MAPTHPGDMEN1KMT2ANPSR1 | |
| SCHEMBL5871662 | 0.80 | MAPT (0.45) | MAPTHPGDMEN1KMT2ANPSR1 | |
| SCHEMBL5872078 | 0.80 | MEN1 (0.72) | MAPTHPGDMEN1KMT2ANPSR1 | |
| SCHEMBL11504105 | 0.79 | ALDH1A1 (0.51) | MAPTHPGDMEN1KMT2ALMNA | |
| SCHEMBL11504106 | 0.79 | ALDH1A1 (0.51) | MAPTHPGDMEN1KMT2ALMNA | |
| SCHEMBL8138421 | 0.78 | MAPT (0.50) | MAPTHPGDMEN1KMT2ANPSR1 | |
| SCHEMBL3519645 | 0.78 | KDM4E (0.62) | MAPTHPGD | |
| SCHEMBL5871929 | 0.78 | KMT2A (0.54) | MAPTMEN1KMT2ANPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5473001-A | Heat and oxidation resistance; photostability | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-12-05 | — | — | US | claimed |
| US-5241067-A | Imparting heat, light and oxidation resistance to polymers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-08-31 | — | — | US | claimed |
| CN-1266151-C | Naphthyridine derivatives | OTSUKA PHARMA CO LTD (JP) | 2006-07-26 | — | — | CN | disclosed |
| US-7071187-B2 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2006-07-04 | — | — | US | disclosed |
| CN-1547581-A | Naphthyridine derivatives | 株式会社大V制药工场 | 2004-11-17 | — | — | CN | disclosed |
| US-20040214853-A1 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-10-28 | — | — | US | disclosed |
| EP-1426374-A1 | NAPHTHYRIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-5473001-A | Heat and oxidation resistance; photostability | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-12-05 | — | — | US | disclosed |
| US-5408008-A | Piperidinyl phthalimide hindered amine light stabilizers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-04-18 | — | — | US | disclosed |
| US-5241067-A | Imparting heat, light and oxidation resistance to polymers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| EP-0294818-A2 | Hindered amine light stabilizers containing aromatic carboxy groups and derivatives | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1988-12-14 | — | — | EP | disclosed |
| US-4159270-A | Bichromophoric benzotriazole-styrene ultraviolet stabilizers | EASTMAN KODAK COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-4158658-A | Bichromophoric benzoxazole-styrene ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1979-06-19 | — | — | US | disclosed |
| US-4105631-A | MULTICHROMOPHORIC ULTRAVIOLET STABILIZERS AND THEIR USE IN ORGANIC COMPOSITIONS | EASTMAN KODAK COMPANY (US) | 1978-08-08 | — | — | US | disclosed |
| US-4075162-A | BICHROMOPHORIC BENZOXAZOLE-STYRENE ULTRAVIOLET STABILIZERS AND THEIR USE IN ORGANIC COMPOSITIONS | EASTMAN KODAK COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4070337-A | Bichromophoric benzotriazole-styrene ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1978-01-24 | — | — | US | disclosed |
| US-4043973-A | PIGMENTS, COLORANTS, FILLERS, REINFORCING AGENTS | EASTMAN KODAK COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-3936419-A | Multichromophoric ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214853-A1 | Naphthyridine derivatives | MT-ND1, OPRD1, NR0B1 | MAPT 2184/4885HPGD 1690/4885MEN1 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.